Broadview Ventures Inc’s Post

🌟 Transforming NCD Care: Smart Remote Monitoring for Hypertension! 🌟 Empowering patients, transforming outcomes! 🚀 Remote monitoring technology, coupled with AI, is revolutionizing NCD care, especially for hypertension management. 📊 Data-Driven Insights: Monitor blood pressure trends in real time, enabling proactive adjustments to treatment plans. 🔍 Early Intervention: Detect potential complications early, leading to better outcomes and reduced hospitalizations. 🧠 AI-Powered Analytics: Harness AI for advanced data analysis, personalized risk assessments, and tailored interventions. 👩⚕️ Personalized Care: Healthcare providers can offer personalized guidance and support, improving patient engagement and adherence. Join the digital health revolution and make a difference in NCD care! 💪 #NCDs #HypertensionManagement #RemoteMonitoring #MedArc #DigitalHealth #HealthTech

US HCPs: A stable access platform: radial access with #BMX81 and #MIDWAY 62 optimizing support for FRED X deployment in the ICA terminus to manage bilobed aneurysm. Courtesy of Dr. Ben Yim and Dr. Ira Finch! Rx only. Risk: peninc.info/risk Clinical results may vary.

The reason why the Golden Circle from Simon Sinek is relevant is because it is genius in its simplicity. WHAT you do and HOW you do it is trivial when compared to 𝗪𝗛𝗬 you do it. A VDD system senses in the atrium (ok…) and uses a couple of sensors to do it (meh…). 𝙒𝙝𝙮 𝙙𝙤 𝙬𝙚 𝙘𝙖𝙧𝙚? * We can prevent stroke faster and more efficiently * We can uncover silent (sometimes deadly) arrhythmias that VVI can’t, and can treat them quickly * We can put less stuff in a patient’s body, which means fewer complications and money saved for a taxed healthcare system * We can increase patient quality of life by vastly reducing the incidence of inappropriate shocks The Dx system is simply the means used on the way to better patient outcomes. Now, run through the same analysis for VVI… #stroke #strokeprevention #afib #atrialfibrillation #ablation #epeeps BIOTRONIK

Quentin Blackford, iRhythm President and CEO, recently took part in a timely Fortune Brainstorm Health 2024 panel discussion on “Reimagining Hospitals and Doctors Offices of the Future.” How is iRhythm reimagining hospitals and doctors offices of the future?  We are disrupting the industry by redefining how cardiac arrhythmias are diagnosed. Learn more at iRhythmTech.com #FortuneHealth #iRhythm #Zio

As it turns out, there’s a lot more to this story than just hemodynamics... that’s only the beginning. Huge congratulations to everyone involved in the #SMARTtrial… A ‘Small’ study with a big impact and even bigger implications for how aortic stenosis is treated. My big takeaways today were: - Better performance is a quality that we innately understand drives success and quality. While dysfunction is a state we actively seek to avoid - in any capacity… whether it’s Aviation or Annuli, performance absolutely matters. Starting off w/ a 32% ∆ at 12 months is not something to be taken lightly… - Evolut TAVI is the gold standard in valve therapy for #SmallAnnulusAorticStenosis - Evolut treats women with #aorticstenosis better. #SAAS #medtronicemployee #TAVR .

The #SMARTtrial 1-year outcomes show Evolut™️ #TAVR delivers superior valve performance vs. SAPIEN platform in small annulus patients with excellent early patient outcomes at 1 year. Explore the key takeaways. https://bit.ly/3WFmv1k Risk info: https://bit.ly/4dAKt3M

SMART Trial Fantastic result in small annulus with Evolut platform

Last year at THT and now published in JACC, we shared breaking meta-analysis data validating the use of remote hemodynamic monitoring with Abbott's CardioMEMS HF System as a clinically proven, life-extending option for people living with chronic heart failure. This year, that body of evidence continues to grow.    #AbbottProud to hear incredible data presented at #THT2024 by Dr. Michael R. Zile yesterday, showing PA pressures, as measured by CardioMEMS, are predictive of mortality, regardless of ejection fraction. This is significant in multiple ways; supporting an additional layer of proactive risk assessment for a wider range of heart failure patients and confirming the ability to remotely monitor PA pressures can help physicians deliver more effective HF treatment decisions, potentially improving survival and quality life.    US Safety Info: https://lnkd.in/gSpBANsp   #CardioMEMS #RemoteMonitoring #HeartFailure

🌟Spotlight on Stroke Care: Part 2 🌟 Modified Rankin Scale (mRS): A Popular Stroke Outcome Assessment in Clinical Research Why it matters: The mRS is indispensable for evaluating stroke outcomes, playing a pivotal role in both clinical trials and routine practice. Its accurate application ensures better patient care and more reliable data. Solution Highlight: Building on our commitment to innovation, BlueCloudX technology revolutionizes the delivery, tracking, and management of the mRS. Our solution ensures compliance, minimizes data variance, and upholds the highest standards of human subject protection. To Learn more: https://lnkd.in/gfrxzByp Stay tuned for more insights on how we're transforming stroke care! 💙 #StrokeCare #HealthcareInnovation #BlueCloudX #ModifiedRankinScale #ClinicalTrials

US HCPs: We can’t wait to see you in Houston at #2024CNS! Learn more about minimally invasive (19F) neuro evacuation with powerful and controlled aspiration for clot removal with #Artemis NOW with Penumbra #ENGINE   Rx only. Risk: peninc.info/risk Clinical results may vary